NeoPharm CO. LTD (092730) — Working Capital to Net Assets Ratio
NeoPharm CO. LTD (092730) has a Working Capital to Net Assets ratio of 79.4% as of September 2025. Working capital of ₩149.57 Billion (current assets of ₩167.47 Billion minus current liabilities of ₩17.90 Billion) is measured against net assets of ₩188.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See NeoPharm CO. LTD (092730) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NeoPharm CO. LTD Working Capital to Net Assets (2012–2024)
This chart shows how NeoPharm CO. LTD's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 79.4%, reflecting working capital of ₩149.57 Billion against net assets of ₩188.40 Billion KRW. For the complete balance sheet picture, see 092730 current and non-current assets.
Annual Working Capital to Net Assets for NeoPharm CO. LTD (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for NeoPharm CO. LTD from 2012 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check NeoPharm CO. LTD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 78.0% | ₩137.92 Billion | ₩176.88 Billion | ₩153.05 Billion | ₩15.13 Billion | ▲ +4.5 pp |
| 2023 | 73.5% | ₩117.56 Billion | ₩160.03 Billion | ₩134.50 Billion | ₩16.94 Billion | ▼ -9.6 pp |
| 2022 | 83.1% | ₩118.13 Billion | ₩142.21 Billion | ₩131.27 Billion | ₩13.14 Billion | ▼ -0.2 pp |
| 2021 | 83.3% | ₩108.54 Billion | ₩130.30 Billion | ₩121.48 Billion | ₩12.94 Billion | ▼ -0.5 pp |
| 2020 | 83.8% | ₩98.67 Billion | ₩117.72 Billion | ₩113.55 Billion | ₩14.88 Billion | ▼ -0.2 pp |
| 2019 | 84.1% | ₩88.85 Billion | ₩105.69 Billion | ₩101.68 Billion | ₩12.83 Billion | ▲ +6.4 pp |
| 2018 | 77.7% | ₩46.04 Billion | ₩59.29 Billion | ₩58.94 Billion | ₩12.89 Billion | ▲ +4.0 pp |
| 2017 | 73.6% | ₩35.03 Billion | ₩47.58 Billion | ₩44.05 Billion | ₩9.01 Billion | ▲ +6.3 pp |
| 2016 | 67.3% | ₩25.95 Billion | ₩38.57 Billion | ₩33.71 Billion | ₩7.76 Billion | ▲ +19.2 pp |
| 2015 | 48.0% | ₩15.67 Billion | ₩32.62 Billion | ₩23.05 Billion | ₩7.38 Billion | ▲ +5.7 pp |
| 2012 | 42.3% | ₩12.67 Billion | ₩29.92 Billion | ₩15.98 Billion | ₩3.31 Billion | — |